Onderneming Sangamo Therapeutics, Inc.
Aandelen
SGMO
US8006771062
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,493 USD | -5,36% | -4,46% | -9,26% |
22/03 | Sangamo Therapeutics prijst $24 miljoen Geregistreerd Direct Aanbod | MT |
14/03 | Sangamo Therapeutics duwt neurologieprogramma's richting klinische ontwikkeling, zegt Wedbush | MT |
Vakgebied
Aantal werknemers: 405
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Zinc Finger Protein
100,0
%
| 111 | 100,0 % | 176 | 100,0 % | +58,34% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 111 | 100,0 % | 176 | 100,0 % | +58,34% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alexander Macrae
CEO | Chief Executive Officer | 61 | 01-06-16 |
Director of Finance/CFO | 46 | 01-03-19 | |
Gregory Davis
CTO | Chief Tech/Sci/R&D Officer | - | 01-05-20 |
Phillip Ramsey
CTO | Chief Tech/Sci/R&D Officer | - | - |
Louise Wilkie
IRC | Investor Relations Contact | - | 01-09-20 |
Amy Pooler
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | 01-09-19 | |
Scott Willoughby
LAW | General Counsel | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Peg Horn
BRD | Director/Board Member | 61 | 15-12-22 |
James Meyers
BRD | Director/Board Member | 58 | 22-11-19 |
H. Parker
CHM | Chairman | 68 | 19-06-14 |
Kenneth Hillan
BRD | Director/Board Member | 63 | 11-09-20 |
Robert Carey
BRD | Director/Board Member | 65 | 01-06-16 |
Karen Smith
BRD | Director/Board Member | 56 | 28-06-18 |
Alexander Macrae
CEO | Chief Executive Officer | 61 | 01-06-16 |
John Markels
BRD | Director/Board Member | 58 | 11-02-20 |
Courtney Beers
BRD | Director/Board Member | 54 | 15-12-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 207 495 609 | 191 497 330 ( 92,29 %) | 0 | 92,29 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-9,26% | 102 mln. | |
-1,51% | 104 mld. | |
+3,22% | 97,42 mld. | |
+1,51% | 22,2 mld. | |
-16,53% | 21,23 mld. | |
-8,77% | 18,33 mld. | |
-42,33% | 16,35 mld. | |
-20,09% | 15,06 mld. | |
+5,47% | 13,98 mld. | |
+28,85% | 11,66 mld. |
- Beurs
- Aandelen
- Koers SGMO
- Onderneming Sangamo Therapeutics, Inc.